Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Key features that set our library apart include:
partner
Reaxense
upacc
O60825
UPID:
F262_HUMAN
Alternative names:
6PF-2-K/Fru-2,6-P2ase heart-type isozyme
Alternative UPACC:
O60825; O60824; Q5VVQ3; Q5VVQ4; Q9H3P1
Background:
The 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2, known as 6PF-2-K/Fru-2,6-P2ase heart-type isozyme, plays a pivotal role in the synthesis and degradation of fructose 2,6-bisphosphate. This enzyme is crucial for regulating glycolysis and gluconeogenesis, processes essential for energy production and glucose metabolism in the body.
Therapeutic significance:
Understanding the role of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 could open doors to potential therapeutic strategies. Its critical function in energy metabolism makes it a potential target for addressing metabolic disorders.